Naplasol acquisition news – Belgium-based Naplasol Acquired mycoprotein company Mycorena

Read also - BrowserStack Acquisition News – BrowserStack Acquires Bird Eats Bug, Launches Bug Capture to Accelerate Its Test Platform Vision

Mycorena develops innovative fungi technology to provide next-generation food ingredients. Its flagship product, Promyc®, is a nutritious and sustainable mycoprotein. The quality of Promyc® is unique in terms of its neutral taste and strong fibrous texture.

Wim Slee, co-CEO of VEOS Group said, “Both companies, Naplasol and Mycorena, are active in the same field and have complementary knowledge and products of which we can benefit in the future, We are proud that we can continue the story of Mycorena, as we strongly believe in the future of mycoproteins. Mycoproteins are clearly a sustainable protein alternative, with a lower CO2, land and water footprint compared to other plant-based proteins,”.

Ramkumar Nair PhD, Founder of Mycorena said, "Mycorena has been on an exciting journey toward becoming a leading player in the mycoprotein industry. The acquisition and merger with Naplasol offer a unique opportunity to build on the foundation we have established. We look forward to seeing Mycorena continue to thrive under the strong industrial expertise of the Veos Group,".

About Naplasol

Naplasol specializes in the production of essential protein through fermentation technology. As part of the VEOS Group, we are one of the global leaders in the protein market. VEOS Group, founded in 1974 and headquartered in Belgium, operates production facilities worldwide for the food, pet food and feed industries, supported by a global sales network.